209 results
Page 4 of 11
6-K
EX-99.1
h07 0m6kvtwi
26 Jan 22
Galapagos creates new subscription right plan
5:30pm
6-K
EX-99.1
l125h04rsm 6t
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
qy4eh7dd27
13 Jan 22
Galapagos creates new subscription right plan
4:32pm
6-K
EX-99.1
8emnne
10 Jan 22
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
3:12pm
6-K
EX-99.1
y3rnjd j8qr4cl9h
6 Dec 21
Current report (foreign)
6:00am
6-K
EX-99.1
eqnkrhwi
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
88oa2xdwnhu
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.1
h90cemy9f p06
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
z1u24wdjrn4iwybay4
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
qj5nvvcmrto zqua90q
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
imil11h
21 Sep 21
Current report (foreign)
12:00am
6-K
EX-99.1
p1c 8o9zi39ick
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.1
2fl5vtf5vycgnl8 pl
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.1
lvcr2hj rfx
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
yehb569s46v xmoayl1
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
7bf0nc
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
EX-99.1
j3dsln3eyypx 1snbz2
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
y6000ep2p 03q
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
0sfmnd476c8o6u
8 Jun 21
Current report (foreign)
6:14am
6-K
EX-99.1
zwclildktvpijhizn
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am